Winning cardiometabolic deals requires equipping reps to respond credibly to clinical scrutiny, demonstrate ROI to employers and payers, and navigate long buying committees – using claims that are cleared, not improvised. Most teams leave this up to whatever each rep can piece together. We build the enablement system that equips every rep with the cleared proof, economic model, and objection handling needed to close.
The Challenge
Each rep tells a different story, and some of those claims were never cleared
Without a single source of enablement, reps assemble their own decks and answers, and in a clinical category that means claims going out that legal and regulatory never reviewed. That inconsistency is both a conversion problem and a compliance exposure, because a recorded overclaim in a sales deck is a liability. Cardiometabolic buyers also compare notes across a committee and notice when the story shifts. A cleared, consistent enablement system is the fix, and most teams do not have one.
Reps cannot demonstrate ROI to buyers focused on total cost of care
Employers and payers buy cardiometabolic solutions on economics – avoided claims, total cost of care – and a rep without a credible ROI model has nothing to counter a procurement spreadsheet with. Selling on features instead of financial impact turns a differentiated product into a line-item price negotiation. In this category the economic case is often the deciding factor, and leaving reps to build it ad hoc means they mostly do not. Enablement has to put a defensible ROI model in every rep's hands.
Reps stall in long committees without a playbook for every stakeholder
Cardiometabolic deals move through benefits, finance, clinical, and sometimes broker stakeholders, each with different concerns, and reps without a multi-threading playbook stall out or get single-threaded on one champion who cannot close alone. The long cycle amplifies every misstep. Reps need to know which stakeholder cares about what and how to move the deal across the committee. Without that map, promising deals die in the middle of the funnel.
New reps take too long to ramp because the knowledge stays in people's heads
When the clinical context, objection handling, and deal playbook are tribal knowledge, every new hire ramps slowly and unevenly, and your best sellers become bottlenecks. In a growth-stage cardiometabolic company that slow ramp directly caps how fast you can scale revenue. The knowledge that makes your top rep effective needs to be captured and systematized, not left to osmosis. Enablement is how you make the whole team perform closer to your best.
How We Support You
We begin by capturing what truly wins. We join deals and debrief your best reps to uncover the clinical framing, objection handling, and committee navigation that already close business, along with the recurring reasons deals are lost. In cardiometabolic sales, that hard-earned knowledge usually sits in a few people's heads, and turning it into a system is the foundation for everything that follows.
Next, we build the cleared proof toolkit. Working with your clinical and legal teams, we translate your evidence into sales-ready proof points approved for external use, so reps no longer improvise claims that have not been reviewed. The result is one consistent, compliant story for the team and less regulatory exposure from ad hoc decks.
We then create an ROI model reps can actually use. We build a defensible economic model linking your product to avoided claims and total cost of care, in a format a rep can walk through live with an employer or payer. This enables your team to compete on economics rather than being pulled into price negotiations, and it is the element most enablement programs overlook.
For execution, we put together the complete system – cleared decks and one-pagers, objection-handling guides, a stakeholder-by-stakeholder committee playbook, and a ramp path for new hires – then train the team to use it rather than simply handing it over. We operate within your current sales process and tools so the enablement gets adopted instead of shelved.
For measurement, we monitor ramp time, win rate, deal velocity, and story consistency across reps. We assess whether the enablement is being used and whether it changes the numbers, then improve assets that are not resonating in real calls. Enablement reps do not use becomes shelfware, so we design against that from day one.
What sets us apart is that we deliver sales enablement as embedded operators who participate in deals and understand cardiometabolic buyers – not as a training vendor that delivers a course. In a clinical, committee-driven category, enablement works only when it comes from actual winning deals and stays current, which is exactly how we approach it.
What we deliver
- Winning-and-losing deal debrief – captured clinical framing, objection handling, and committee navigation from your best reps
- Cleared proof toolkit – evidence turned into sales-ready, legally approved proof points for one consistent, compliant story
- Runnable ROI model connecting the product to avoided claims and total cost of care for employer and payer buyers
- Full enablement system – cleared decks, objection guides, a stakeholder-by-stakeholder committee playbook, and a new-hire ramp path
- Adoption and impact tracking – ramp time, win rate, deal velocity, and story consistency, with assets refined on real usage
In cardiometabolic sales, your strongest rep wins with a cleared clinical story and a runnable ROI model – but that knowledge is stuck in their head. Enablement means helping the entire team sell like your best rep, without allowing anyone to improvise a claim that has not been reviewed.
Our Methodology
We deliver sales enablement through a 90-day sprint. The first 30 days focus on capture: we join deals, debrief top reps and review lost deals, then extract the winning clinical framing, objection handling, and committee navigation. Days 30 to 60 focus on the build: we develop the cleared proof toolkit with legal and clinical, construct the runnable ROI model, and create the decks, objection guides, committee playbook, and ramp path. Days 60 to 90 cover rollout and measurement: we train the team, instrument adoption and win rate, and improve assets that are not landing in live calls.
Unlike a training vendor, we create enablement from real winning deals and keep it embedded in the sales motion. A generic sales course cannot prepare a rep to handle a medical director's clinical question or a benefits leader's ROI challenge. We capture what is already winning, clear it for compliance, and measure the work against ramp time, win rate, and deal velocity instead of course completion – because enablement that reps do not use is simply shelfware.
Our Working Model
The first 30 days focus on capture and diagnosis. We participate in live deals, debrief your top reps and examine recent losses, then identify the clinical framing, objection handling, and committee navigation that genuinely move deals forward. You will see clearly what your best reps do differently from the rest, creating the blueprint for the system.
Days 30 to 60 are dedicated to the build. Alongside your clinical and legal teams, we develop the cleared proof toolkit, construct the runnable ROI model, and create the decks, objection guides, committee playbook, and ramp path. We collaborate closely with sales leadership because the system must match how your team actually sells and closes. From your side, we need access to reps, deal data, and clinical and legal contacts for clearance.
Days 60 to 90 cover rollout and measurement. We train the team to use the system, instrument adoption and win rate, and improve assets that are not working in real calls. Most engagements last three to six months, and many continue as an ongoing enablement function because the toolkit must remain current as new evidence, products, and objections emerge.
Our cadence includes a weekly working session with sales leadership, supported by async asset iteration. Rather than delivering a course and walking away, we remain embedded in the deals, keeping the enablement grounded in reality and actively used.
- New-rep ramp time
- Win rate and deal velocity
- Story consistency and claim compliance
- Adoption of the enablement system
If your diabetes & cardiometabolic health company needs sales enablement leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a sales enablement engagement cost for diabetes and cardiometabolic health companies?
We price sales enablement as a fixed monthly fee across a three-to-six-month sprint, with the range based on your sales team's size and the amount of proof-clearance and ROI-modeling work required. Unlike a training vendor offering a generic course, our approach creates the system from your actual winning deals and clears it for compliance.
How soon will we see results from a sales enablement engagement?
Reps typically have the cleared proof toolkit and ROI model in hand within about 60 days, and they feel the impact immediately in their next clinical and ROI conversations. Because cardiometabolic sales cycles are long, win rate and deal velocity require a sales cycle to evaluate, while improvements in new-rep ramp become visible with your next hires.
How does the sales enablement team work with our existing staff?
We work directly with your sales leadership, reps, and clinical and legal teams because the system comes from real deals and must be cleared for compliance. We require access to reps for debriefs and training, deal data, and clinical and legal contacts to clear the proof.
How is Winston Francois different from a conventional sales training vendor?
A training vendor provides a generic course and then leaves. We create enablement from your actual winning deals, clear the proof for compliance, and build a runnable ROI model aligned with how employers and payers really buy.
How is ROI measured for a sales enablement engagement?
We track new-rep ramp time, win rate, deal velocity, and story consistency and compliance across reps. We also monitor whether the system is truly being used in live deals, since enablement that goes unused delivers no return.
What kind of diabetes and cardiometabolic health company is best suited to this service?
This service is designed for companies with roughly 5M to 100M in ARR and a sales team selling to employers, payers, or health systems, where inconsistent stories, slow ramp, and ROI selling are limiting close rates. It works best when you already have a few successful reps and real evidence for building cleared proof. If you are pre-revenue or still establishing your sales motion, enablement is too early. The first step is a strategy call to identify where your deals are currently stalling.
